US-funded hepatitis B vaccine trial cancelled in Guinea-Bissau
A proposed trial of a hepatitis B vaccine on newborn babies in Guinea-Bissau has been cancelled following accusations of being "unethical" and "neocolonial". The trial, designed to involve 14,000 newborns with half withheld the WHO-recommended vaccine, drew criticism for potentially subjecting vulnerable African populations to risks researchers would not accept in wealthier countries.
22 hours ago · Joy Online →